Growth Metrics

Enanta Pharmaceuticals (ENTA) Cash from Operations Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 74.39%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 158.60%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 46.95%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 46.95%
Dec 31, 2025 30.37%
Sep 30, 2025 37.61%
Jun 30, 2025 218.48%
Mar 31, 2025 52.84%
Dec 31, 2024 32.76%
Sep 30, 2024 51.86%
Jun 30, 2024 54.01%
Mar 31, 2024 -107.51%
Dec 31, 2023 29.89%
Sep 30, 2023 -39.06%
Jun 30, 2023 -8.53%
Mar 31, 2023 47.74%
Dec 31, 2022 -168.56%
Sep 30, 2022 26.10%
Jun 30, 2022 -0.33%
Mar 31, 2022 -476.00%
Dec 31, 2021 10.87%
Sep 30, 2021 -35.96%
Jun 30, 2021 -557.44%
Mar 31, 2021 -131.20%
Dec 31, 2020 -220.44%
Sep 30, 2020 -280.94%
Jun 30, 2020 -277.18%
Mar 31, 2020 -51.23%
Dec 31, 2019 -59.14%
Sep 30, 2019 -69.85%
Jun 30, 2019 -37.43%
Mar 31, 2019 497.02%
Dec 31, 2018 586.19%
Sep 30, 2018 -50.54%
Jun 30, 2018 184.40%
Mar 31, 2018 -152.43%
Dec 31, 2017 40.19%
Sep 30, 2017 2,795.48%
Jun 30, 2017 -127.08%
Mar 31, 2017 -129.86%
Dec 31, 2016 -89.51%
Sep 30, 2016 10.48%
Jun 30, 2016 85.13%
Mar 31, 2016 -89.83%
Dec 31, 2015 634.63%
Sep 30, 2015 51.85%
Jun 30, 2015 -140.45%
Mar 31, 2015 2,493.73%
Dec 31, 2014 4.45%
Sep 30, 2014 -97.04%
Jun 30, 2014 692.91%
Mar 31, 2014 -141.16%
Dec 31, 2013 -164.91%
Sep 30, 2013 -47.06%
Jun 30, 2013 -54.70%